| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/18/2003 | US20030175784 Method for detecting, analyzing, and mapping RNA transcripts |
| 09/18/2003 | US20030175781 Method for controlling quality in the construction of oligomer arrays |
| 09/18/2003 | US20030175780 Determining nucleic acids sequence without high resolution separation; for forensics, genetic mapping and medical diagnostics |
| 09/18/2003 | US20030175779 Preparing solid support comprising immobilized biopolymers for detecting, measuring, separating and/or assaying DNA or proteins in a sample |
| 09/18/2003 | US20030175776 Hybridization accelerator and accelerating method |
| 09/18/2003 | US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof |
| 09/18/2003 | US20030175774 Single-tube, ready-to-use assay kits and methods using same |
| 09/18/2003 | US20030175771 Human Transcriptomes |
| 09/18/2003 | US20030175770 Diagnosing cancer in animal and humans via screens which detect extracellular viral nucleotide sequences associated with cell proliferative disease |
| 09/18/2003 | US20030175769 Reagents for improved PCR |
| 09/18/2003 | US20030175768 Method for early diagnosis of, and determination of prognosis in, cancer |
| 09/18/2003 | US20030175766 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/18/2003 | US20030175765 Using oligonucleotide probes for detecting the presence of viral nucleotide sequences; medical, forensic, food, environmental diagnostics; plant protection; veterinary medicine |
| 09/18/2003 | US20030175764 Monitoring interleukin allelic expression to detect occlusive, fragile plaque, restenosive and atherscerotic disorders |
| 09/18/2003 | US20030175763 Identification of an amplified gene and target for drug intervention |
| 09/18/2003 | US20030175761 Using transcriptional profiles to differentiate between lymphatic tissues; anticarcinogenic/antitumor/antiproliferative agents; gene therapies |
| 09/18/2003 | US20030175760 Identifying immunotoxin for treatment of cancers; antitumor/antiproliferative/anticarcinogenic agents |
| 09/18/2003 | US20030175759 Using electrophoresis and restriction fragment length polymorphisms to identify preferential nucleotide sequences in data base |
| 09/18/2003 | US20030175755 Diagnosing sensitivity to oral diseases via analysis of mutation in defensin nnuclelotide sequences and gene expression pattern |
| 09/18/2003 | US20030175753 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 09/18/2003 | US20030175752 Comprises nucleotide sequences coding apyrase and/or hydrolase (NDPase) activity for treating or preventing thrombosis; thrombolytic agents |
| 09/18/2003 | US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 09/18/2003 | US20030175750 Identifying one or more of a plurality of sequences differing by one or more single-base changes; restriction fragment length polymorphisms |
| 09/18/2003 | US20030175749 Annealing control primer and its uses |
| 09/18/2003 | US20030175747 Microfluidic apparatus for detection, separation and classification multiple DNA sequences; restriction fragment length polymorphisms |
| 09/18/2003 | US20030175746 Using oligonucleotide primers complimentary to virulence determinant genes (VDG) for classifying, identifying and diagnosing campylobacter infection |
| 09/18/2003 | US20030175744 Replication primer sequences for identifying ligand-binding domains for detection of neuron odorants, toxic odors and which can be used to manipulate odor response in animals |
| 09/18/2003 | US20030175743 Using probes to detect escherichia or shigella infections; cancer diagnosis |
| 09/18/2003 | US20030175742 Comprises pyrene, perylene, coronene, and/or rubrene groups; solid phase synthesis; for DNA analysis; fluorescent in situ hybridization (FISH) |
| 09/18/2003 | US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening |
| 09/18/2003 | US20030175740 Compositions and methods comprising control nucleic acid |
| 09/18/2003 | US20030175739 Nucleic acids, proteins, and antibodies |
| 09/18/2003 | US20030175737 Quantifying target molecules contained in a liquid |
| 09/18/2003 | US20030175736 Classifying and characterizing prostate gland tissues via monitoring expression of tumor markers such as, hepsin, pim-1, ezh2 or alpha-methylacyl-coa racemase for diagnosing prostate/urogenital health |
| 09/18/2003 | US20030175735 Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activity |
| 09/18/2003 | US20030175734 Diagnostic assay for cancer |
| 09/18/2003 | US20030175732 Chromosomal region containing quantitative trait loci associated with correlating preferential genotype and phenotype with corn digestibility and lignin biosynthesis |
| 09/18/2003 | US20030175729 Method for generating oligonucleotides, in particular for the detection of amplified restriction fragments obtained using aflp |
| 09/18/2003 | US20030175728 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for PCR analysis |
| 09/18/2003 | US20030175727 Peptide nucleic acid probe for detection of yeast |
| 09/18/2003 | US20030175726 Design of artificial genes for use as controls in gene expression analysis systems |
| 09/18/2003 | US20030175725 Mycobacterial diagnostics |
| 09/18/2003 | US20030175723 Methods and compositions for mutation analysis |
| 09/18/2003 | US20030175721 Melanoma risk detection |
| 09/18/2003 | US20030175720 Cluster analysis of genetic microarray images |
| 09/18/2003 | US20030175719 Random array of micro-spheres for the analysis of nucleic acid using enzyme digestion |
| 09/18/2003 | US20030175718 Identifying biomolecules bound to electrode/semiconductor comprised of titania |
| 09/18/2003 | US20030175717 Apparatus and method for predicting treatment response of cancer |
| 09/18/2003 | US20030175716 Method for detecting staphylococcus aureus |
| 09/18/2003 | US20030175714 Method for generating amplified RNA |
| 09/18/2003 | US20030175713 Method for diagnosis of inflammatory diseases using CALGRANULIN C |
| 09/18/2003 | US20030175710 Haplotypes of the TNFRSF11B gene |
| 09/18/2003 | US20030175708 Nucleic acids and proteins from cenarchaeum symbiosum |
| 09/18/2003 | US20030175707 Comprises nucleotide sequences coding prostate specific antigens for identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease in prostate tissue; drug screening; gene therapy |
| 09/18/2003 | US20030175706 Using oligonuclelotide probes for rapid, automated detection of infectious pathogenic agents as well as wild type and mutant gene expression |
| 09/18/2003 | US20030175705 Methods of use for novel single nucleotide polymorphisms of olfactory receptor-like polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175704 Comprises cDNA that are differentially expressed in respiratorny system disorders for diagnosis, treatment and monitoring of lung cancer, chronic obstructive pulmonary disease, emphysema and asthma |
| 09/18/2003 | US20030175702 Electronic array for solid phase synthesis; kits |
| 09/18/2003 | US20030175701 Forensic indentification |
| 09/18/2003 | US20030175698 Retrovirus-specific oligonucleotides and a method for measuring retroviral titer using same |
| 09/18/2003 | US20030175697 Comprises primers which hybridize conserved sequences; polymerase chain reactions; ribonucleases; mass spectrometry; drug screening |
| 09/18/2003 | US20030175696 Comprises primers which hybridize conserved sequences; polymerase chain reactions; ribonucleases; mass spectrometry; drug screening |
| 09/18/2003 | US20030175695 Method for rapid detection and identification of bioagents |
| 09/18/2003 | US20030175693 HIV recombinant vaccine |
| 09/18/2003 | US20030175692 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 09/18/2003 | US20030175690 Method to evaluate the hiv drug sensitivity |
| 09/18/2003 | US20030175689 Gene detecting method |
| 09/18/2003 | US20030175687 Classifiying, evaluating and characterizing microorganisms such as listeria, enterococcus and pseudomonas using flow cytometry and fluorescence; food processing; infection diagnosis |
| 09/18/2003 | US20030175685 Using amino acid sequences to control apoptosis and prevent or treat cancer and viral infections |
| 09/18/2003 | US20030175684 Quantitative epstein barr virus PCR rapid assay |
| 09/18/2003 | US20030175683 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses |
| 09/18/2003 | US20030175680 Methods of treating and preventing bone loss |
| 09/18/2003 | US20030175679 Detecting modulators of ubiquitin conjugating enzyme complex formation; drug screening |
| 09/18/2003 | US20030175678 Monitoring transgenic plants for increased expression of catechin and terpenes |
| 09/18/2003 | US20030175371 Antimicrobial agents isolated from Aloe vera |
| 09/18/2003 | US20030175289 TIE ligands |
| 09/18/2003 | US20030175279 Diagnosing and prophylaxis of tumors, endometriosis and fibroids, by administering Endometrial Steroid Binding Protein II (ESBPII) antagonists, then analyzing the polypeptide concentration in cells, tissues or fluids |
| 09/18/2003 | US20030175254 Separating population based on density and size of cells via elution then cetrifugation; for secretion of neuroendocrine hormones |
| 09/18/2003 | US20030175253 Compositions and methods for diagnosing and treating mental disorders |
| 09/18/2003 | US20030175210 Individualization of therapy with anxiolitics |
| 09/18/2003 | US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy |
| 09/18/2003 | US20030175207 A chelated complex comprised of lantibiotics and a transition or lanthanide metal, for a chemiluminescent assay of bacteria or fungi; binding to grampositive or mycobacterial cells or gramnegative bacteria |
| 09/18/2003 | US20030173284 Separation device |
| 09/18/2003 | CA2813780A1 Genetic products differentially expressed in tumors and use thereof |
| 09/18/2003 | CA2516091A1 Dna and rna conformational switches as sensitive electronic sensors of analytes |
| 09/18/2003 | CA2485142A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
| 09/18/2003 | CA2481312A1 Tagging and recovery of elements associated with target molecules |
| 09/18/2003 | CA2479006A1 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes |
| 09/18/2003 | CA2478924A1 Cancer associated araf1 protein kinase and its uses |
| 09/18/2003 | CA2478640A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors |
| 09/18/2003 | CA2478607A1 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | CA2478605A1 Methods for identifying large subsets of differentially expressed genes based on multivariate microarray data analysis |
| 09/18/2003 | CA2478604A1 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | CA2478593A1 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | CA2478592A1 Genomic screen for epigenetically silenced genes associated with cancer |
| 09/18/2003 | CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 09/18/2003 | CA2478529A1 In vitro serological method of diagnosing infective endocarditis |
| 09/18/2003 | CA2478510A1 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/18/2003 | CA2478486A1 Selective elution of immobilized multiplexed primer extension products |
| 09/18/2003 | CA2478413A1 Genetic products differentially expressed in tumors and use thereof |